Author

Nerea Moreno

Universitat de ValènciaPrimary ORCID profile (0000-0002-5578-192X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nerea MorenoiD1 paper · Universidad Complutense de Madrid

Biology Disciplines

Click to filter author papers

Genetics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Aline Huguet-LachoniD· 2 shared Geneviève GourdoniD· 2 shared Ruben D. ArteroiD· 2 shared A LópeziD· 1 shared Adolfo López de MunainiD· 1 shared Alex Chun KooniD· 1 shared Ana Díaz-Maqueda· 1 shared Anchel González‐BarrigaiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Aline Huguet-LachonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for Myotonic Dystrophy type 1

Irene González-Martínez, Estefanía Cerro-Herreros, Marc Carrascosa-Sàez, Andrea García-Rey, Diego Piqueras‐Losilla, Anna Colom-Rodrigo, Nerea Moreno, Mouli Chakraborty, Aline Huguet-Lachon, Anchel González‐Barriga, Neia Naldaiz‐Gastesi, Martxel Dehesa-Etxebeste, Ana Díaz-Maqueda, Nuria Barquero, Miguel A. Varela, , Ruben D. Artero

This study develops chemically optimized miR-23b antimiRs that enhance muscle uptake and restore MBNL1 function in DM1 models, showing improved efficacy and safety.

The American Journal of Human Genetics · Feb 20, 2026Peer-reviewedGenetics

Upregulation of FasII underlies synergistic neuropathological and behavioral defects in a Drosophila model of myotonic dystrophy

Alex Chun Koon, Ka Yee Winnie Yeung, Lok I Leong, Zhefan Stephen Chen, Shaohong Isaac Peng, Joyce Man See Fung, Yitao Wu, Noah S. Armstrong, Ariadna Bargiela, Nerea Moreno, Javier Poyatos, Juan Jesus Vilchez, Paul Magneron, Aline Huguet-Lachon, Cassandra Kussius Brewer, , Ho Yin Edwin Chan

This study identifies FasII upregulation as a key factor in DM1 neuropathology using a Drosophila model, showing that manipulating FasII isoforms can rescue synaptic and behavioral defects.

bioRxiv · May 26, 2024 · PreprintNeuroscience